Investments
23Portfolio Exits
3Funds
1About Fjord Ventures
Fjord Ventures LLC was founded in mid-2005 and is committed to providing strategic vision and operational excellence to emerging life sciences companies. The Firm is based in Laguna Hills, California.
Fjord Ventures Headquarter Location
26051 Merit Circle
Laguna Hills, California, 92653-7008,
United States
Latest Fjord Ventures News
Nov 16, 2020
Adagio Medical, Inc. , a Laguna Hills, Calif.-based provider of treatments for atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the Continuous Lesion Ablation System (iCLAS™), closed a $42.5m Series E equity financing. Backers included new investors ArrowMark Partners, RA Capital Management and Perceptive Advisors, who joined existing investors including JMR Capital and Fjord Ventures. Tuan Huynh of ArrowMark and Zach Scheiner, PhD of RA Capital Management have been appointed to the Adagio Board of Directors. The company intends to use the funds to further develop the iCLAS™ Investigational Device Exemption (IDE) trial, accelerate the European VT CE-Mark trial, advance the commercialization of the iCLAS system in CE-Mark countries, and continue the development and clinical validation of its pulsed field cryoablation (PFCA) technology. Led by Olav Bergheim, President and CEO, Adagio is developing innovative cryoablation technologies that create continuous, linear, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. FinSMEs
Fjord Ventures Investments
23 Investments
Fjord Ventures has made 23 investments. Their latest investment was in Adagio Medical as part of their Series E on November 11, 2020.
Fjord Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/13/2020 | Series E | Adagio Medical | $42.5M | No | 2 | |
1/10/2020 | Series E | PreludeDX | $10M | No | 1 | |
7/27/2018 | Series D | PreludeDX | $9M | No | 1 | |
9/18/2017 | Growth Equity | |||||
3/16/2017 | Series C |
Date | 11/13/2020 | 1/10/2020 | 7/27/2018 | 9/18/2017 | 3/16/2017 |
|---|---|---|---|---|---|
Round | Series E | Series E | Series D | Growth Equity | Series C |
Company | Adagio Medical | PreludeDX | PreludeDX | ||
Amount | $42.5M | $10M | $9M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 2 | 1 | 1 |
Fjord Ventures Portfolio Exits
3 Portfolio Exits
Fjord Ventures has 3 portfolio exits. Their latest portfolio exit was Sonendo on October 29, 2021.
Fjord Ventures Fund History
1 Fund History
Fjord Ventures has 1 fund, including Fjord Capital Partners I LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
2/19/2010 | Fjord Capital Partners I LP | Early-Stage Venture Capital | Open | $12M | 1 |
Closing Date | 2/19/2010 |
|---|---|
Fund | Fjord Capital Partners I LP |
Fund Type | Early-Stage Venture Capital |
Status | Open |
Amount | $12M |
Sources | 1 |
Fjord Ventures Team
4 Team Members
Fjord Ventures has 4 team members, including current Chief Financial Officer, Hugh A. Neuharth.
Name | Work History | Title | Status |
|---|---|---|---|
Hugh A. Neuharth | Chief Financial Officer | Current | |
Terrance McGovern | Kroll, and CIBC World Markets | Managing Director | Current |
Hugh A Neuharth | Chief Financial Officer | Former | |
Roy C. Cosan | Managing Director | Former |
Name | Hugh A. Neuharth | Terrance McGovern | Hugh A Neuharth | Roy C. Cosan |
|---|---|---|---|---|
Work History | Kroll, and CIBC World Markets | |||
Title | Chief Financial Officer | Managing Director | Chief Financial Officer | Managing Director |
Status | Current | Current | Former | Former |